Izeen Pharma Limited - Due diligence report

A 360° intelligence report on Izeen Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress s…

2013-03-13 Secunderabad, Telangana Strike Off Unlisted Active Non-Compliant
Share
View plans
IP Izeen Pharma Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Izeen Pharma Limited — 360° Intelligence Report

Generated from MCA filings & public records
38/100
Trust Score
Caution Indicated

Izeen Pharma Limited is assessed as Caution Indicated with a Trust Score of 38/100. Izeen Pharma Limited is a public limited indian non-government company incorporated in 2013, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 25 Jun 2026 from the latest processed filings. Izeen Pharma Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Weak
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
38/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
10/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
30/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
35/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
55/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
30/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 35/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Elevated gearing (D/E 38%).

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 10/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2016 - filings overdue.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
VASUDEV KOMARAJU 01234567 Director 01/04/2018 6 yrs Approved
SREE RAMA RATAN VOLETY 01234567 Director 01/04/2018 6 yrs Approved
RAMKUMAR SARMA VISHNUBHOTLA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • SREE RAMA RATAN VOLETY has DIN status "Disqualified by RoC u/s 164(2)".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2016 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
International Capital Partners (india) Limited
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
International Capital Partners (india) Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 55 · Distress 30
Growth signals & trust indicators
Asset base grew 1.42 - capacity expansion.
Operating for 13+ years.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Outside liabilities up 2.1x in a year.
Statutory filings appear overdue.
Adverse company status: Strike Off.
Compliance score is weak (10/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence24/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 4 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment27/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view42/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 12 events
10 Dec 2018
Director appointed
RAMKUMAR SARMA VISHNUBHOTLA (Director)
Director ceased
NARENDRA MALLAKUNTA
01 Apr 2017
Director appointed
SREE RAMA RATAN VOLETY (Director)
Director ceased
HARSHAL SUBHASH VIBHANDIK
06 Mar 2017
Director ceased
JANAKI RAM AJJARAPU
30 Sep 2016
Last AGM held
Annual general meeting
29 Jul 2016
Director ceased
AJJARAPU SURYA NARAYANA MURTY
31 Mar 2016
Latest balance sheet
Filed with ROC
01 Mar 2016
Director ceased
CHITTA SRI VENKATA SRINIVASA JAGANNADHA SARMA
30 Sep 2015
Director ceased
VASUDEV KOMARAJU
04 Jul 2015
Director appointed
VASUDEV KOMARAJU (Director)
13 Mar 2013
Incorporated
Registered with Roc Hyderabad
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 24% - leverage worth monitoring.
Net worth is positive.
3 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2016 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Laxami And Company (Flavours) Private Limited U16008UP1996PTC020209 Kanpur, Uttar Pradesh, India
Finetech Packwell Private Limited U36102GJ2007PTC051108 Ahmedabad, Gujarat, India
Zoic Animal Health Care Private Limited U24232BR2015PTC023631 Patna, Bihar, India
Rhazes Herbal Pharmaceutical Private Limited U24233UP2013PTC055632 Ghaziabad, Uttar Pradesh, India
Ansturm Health Care Private Limited U24232KL2015PTC039369 Sulthan Bathery, Kerala, India
Mother Biotech Private Limited U24232RJ2014PTC044989 Jaipur, Rajasthan, India
Perfect Gums Private Limited U24139MH1995PTC084718 Mumbai, Maharashtra, India
Juvin Pharma Private Limited U24100TG2009PTC064222 Hyderabad, Telangana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Izeen Pharma Limited before audits and certifications: compliance score 10/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Izeen Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 35/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 55/100, margin trends, ownership structure and peer set for Izeen Pharma Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 38/100, distress signals and MSME payment-delay disclosures - know whether Izeen Pharma Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Izeen Pharma Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Izeen Pharma Limited an active company?

Izeen Pharma Limited has MCA status “Strike Off” with a compliance score of 10/100 (Caution Indicated).

Is Izeen Pharma Limited financially healthy?

Izeen Pharma Limited has a Financial Health Score of 30/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Izeen Pharma Limited?

Its overall Trust Score is 38/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Izeen Pharma Limited?

The ultimate holding entity is International Capital Partners (india) Limited. 3 active director(s) are on record.

Does Izeen Pharma Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Izeen Pharma Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 10/100 (Caution Indicated).

Is it risky to lend to Izeen Pharma Limited?

Its Credit Risk Score is 35/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.